Triple-negative breast cancer (TNBC), which lacks expression of estrogen receptor (ER), progesterone receptor (PR), and HER-2, is characterized by poor prognosis and extreme heterogeneity [1], [2]. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.